Atlas Trials

Primary Chemotherapy With Anthracycline Followed by Nab-paclitaxel and Trastuzumab

Clinical trial NCT01432223 · COMPLETED

Trial details

NCT number
NCT01432223
Sponsor
Osaka Medical College
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Breast CancerHER-2 Positive Breast CancerEffects of Chemotherapy
Start date
2011-09-01
Primary completion
2013-11-01
Enrollment
46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.